TYBR Health
Houston, United States
◆ Total Raised
$30M
◆ Stage
series-a
◆ Location
Houston, United States
◆ Founded
2020
◆ Team size
1-10
◆ Links
◆ About TYBR Health
Houston-based healthtech startup that develops the B3 GEL System, a flowable extracellular matrix hydrogel designed to protect tendons and soft tissue from scarring during orthopedic surgery.
◆ What sets it apart
Its B3 GEL System is a flowable, bioresorbable ECM hydrogel that conforms to complex anatomy and creates a temporary protective barrier during the critical healing window.
◆ Sectors
◆ Business
Modelhardware
CustomerOrthopedic surgeons, sports medicine surgeons, and other surgical teams treating tendon, ligament, muscle, and soft-tissue injuries
◆ Notable
- FDA 510(k) clearance for the B3 GEL System in June 2025
- First U.S. clinical use of the B3 GEL System announced in January 2026
- $30 million Series A financing announced in July 2026
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does TYBR Health do?
Houston-based healthtech startup that develops the B3 GEL System, a flowable extracellular matrix hydrogel designed to protect tendons and soft tissue from scarring during orthopedic surgery.
Where is TYBR Health based?
TYBR Health is based in Houston, United States, founded in 2020.
How much has TYBR Health raised?
TYBR Health has raised $30M in tracked funding and is currently at the series-a stage.
Who has invested in TYBR Health?
Investors in TYBR Health include Vensana Capital, Mutual Capital Partners and Neovate Capital Partners.